Literature DB >> 22737591

Molecular signaling mechanisms of apoptosis in hereditary non-polyposis colorectal cancer.

Samar Hassen1, Nawab Ali, Parimal Chowdhury.   

Abstract

Colorectal cancer is the second most leading cause of cancer related deaths in the western countries. One of the forms of colorectal cancer is hereditary non-polyposis colorectal cancer (HNPCC), also known as "Lynch syndrome". It is the most common hereditary form of cancer accounting for 5%-10% of all colon cancers. HNPCC is a dominant autosomal genetic disorder caused by germ line mutations in mismatch repair genes. Human mismatch repair genes play a crucial role in genetic stability of DNA, the inactivation of which results in an increased rate of mutation and often a loss of mismatch repair function. Recent studies have shown that certain mismatch repair genes are involved in the regulation of key cellular processes including apoptosis. Thus, differential expression of mismatch repair genes particularly the contributions of MLH1 and MSH2 play important roles in therapeutic resistance to certain cytotoxic drugs such as cisplatin that is used normally as chemoprevention. An understanding of the role of mismatch repair genes in molecular signaling mechanism of apoptosis and its involvement in HNPCC needs attention for further work into this important area of cancer research, and this review article is intended to accomplish that goal of linkage of apoptosis with HNPCC. The current review was not intended to provide a comprehensive enumeration of the entire body of literature in the area of HNPCC or mismatch repair system or apoptosis; it is rather intended to focus primarily on the current state of knowledge of the role of mismatch repair proteins in molecular signaling mechanism of apoptosis as it relates to understanding of HNPCC.

Entities:  

Keywords:  Apoptosis; Colorectal cancer; DNA mismatch repair proteins; Hereditary non-polyposis colorectal cancer; Molecular signaling mechanisms

Year:  2012        PMID: 22737591      PMCID: PMC3382705          DOI: 10.4291/wjgp.v3.i3.71

Source DB:  PubMed          Journal:  World J Gastrointest Pathophysiol        ISSN: 2150-5330


  52 in total

1.  Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer.

Authors:  R C Niessen; M J W Berends; Y Wu; R H Sijmons; H Hollema; M J L Ligtenberg; H E K de Walle; E G E de Vries; A Karrenbeld; C H C M Buys; A G J van der Zee; R M W Hofstra; J H Kleibeuker
Journal:  Gut       Date:  2006-04-24       Impact factor: 23.059

Review 2.  DNA mismatch repair.

Authors:  Thomas A Kunkel; Dorothy A Erie
Journal:  Annu Rev Biochem       Date:  2005       Impact factor: 23.643

Review 3.  Signalling cell cycle arrest and cell death through the MMR System.

Authors:  Vincent O'Brien; Robert Brown
Journal:  Carcinogenesis       Date:  2005-12-06       Impact factor: 4.944

4.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

5.  The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.

Authors:  S Jacob; M Aguado; D Fallik; F Praz
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

Review 6.  The role of DNA mismatch repair in drug resistance.

Authors:  D Fink; S Aebi; S B Howell
Journal:  Clin Cancer Res       Date:  1998-01       Impact factor: 12.531

7.  MLH1 and MSH2 protein immunohistochemistry is useful for detection of hereditary non-polyposis colorectal cancer in young patients.

Authors:  F Paraf; M Gilquin; M Longy; B Gilbert; P Gorry; B Petit; F Labrousse
Journal:  Histopathology       Date:  2001-09       Impact factor: 5.087

8.  Mismatch repair protein deficiency compromises cisplatin-induced apoptotic signaling.

Authors:  Ryan P Topping; John C Wilkinson; Karin Drotschmann Scarpinato
Journal:  J Biol Chem       Date:  2009-03-13       Impact factor: 5.157

Review 9.  Platinum resistance: the role of DNA repair pathways.

Authors:  Lainie P Martin; Thomas C Hamilton; Russell J Schilder
Journal:  Clin Cancer Res       Date:  2008-03-01       Impact factor: 12.531

10.  hMSH2 is the most commonly mutated MMR gene in a cohort of Greek HNPCC patients.

Authors:  A Apessos; M Mihalatos; I Danielidis; G Kallimanis; N J Agnantis; J K Triantafillidis; G Fountzilas; P A Kosmidis; E Razis; V A Georgoulias; G Nasioulas
Journal:  Br J Cancer       Date:  2005-01-31       Impact factor: 7.640

View more
  12 in total

1.  The downregulation of Bcl-xL/Bcl-2-associated death promoter indicates worse outcomes in patients with small cell lung carcinoma.

Authors:  Yaoyang Yu; Zhaokui Zhong; Yaowu Guan
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  Expression of the apoptosis repressor with caspase recruitment domain (ARC) in liver metastasis of colorectal cancer and its correlation with DNA mismatch repair proteins and p53.

Authors:  Csaba Tóth; Jeannine Meinrath; Esther Herpel; Jutta Derix; Jochen Fries; Reinhard Buettner; Peter Schirmacher; Sebastian Heikaus
Journal:  J Cancer Res Clin Oncol       Date:  2015-12-31       Impact factor: 4.553

3.  A significant imbalance in mitosis versus apoptosis accelerates the growth rate of sessile serrated adenoma/polyps.

Authors:  Akira Endo; Hirotaka Koizumi; Makiko Takahashi; Tomohiro Tamura; Shinobu Tatsunami; Yoshiyuki Watanabe; Masayuki Takagi
Journal:  Virchows Arch       Date:  2013-01-06       Impact factor: 4.064

Review 4.  The significance of genetics for cholangiocarcinoma development.

Authors:  Luca Maroni; Irene Pierantonelli; Jesus M Banales; Antonio Benedetti; Marco Marzioni
Journal:  Ann Transl Med       Date:  2013-10

Review 5.  Apoptotic pathways as a therapeutic target for colorectal cancer treatment.

Authors:  Aman M Abraha; Ezra B Ketema
Journal:  World J Gastrointest Oncol       Date:  2016-08-15

Review 6.  Potential Role of Tocotrienols on Non-Communicable Diseases: A Review of Current Evidence.

Authors:  Sok Kuan Wong; Yusof Kamisah; Norazlina Mohamed; Norliza Muhammad; Norliana Masbah; Nur Azlina Mohd Fahami; Isa Naina Mohamed; Ahmad Nazun Shuid; Qodriyah Mohd Saad; Azman Abdullah; Nur-Vaizura Mohamad; Nurul' Izzah Ibrahim; Kok-Lun Pang; Yoke Yue Chow; Benjamin Ka Seng Thong; Shaanthana Subramaniam; Chin Yi Chan; Soelaiman Ima-Nirwana; And Kok-Yong Chin
Journal:  Nutrients       Date:  2020-01-19       Impact factor: 5.717

Review 7.  Biology of colorectal cancer.

Authors:  Francisco Arvelo; Felipe Sojo; Carlos Cotte
Journal:  Ecancermedicalscience       Date:  2015-04-09

8.  DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells.

Authors:  Shinichiro Fukuhara; Inik Chang; Yozo Mitsui; Takeshi Chiyomaru; Soichiro Yamamura; Shahana Majid; Sharanjot Saini; Hiroshi Hirata; Guoren Deng; Ankurpreet Gill; Darryn K Wong; Hiroaki Shiina; Norio Nonomura; Rajvir Dahiya; Yuichiro Tanaka
Journal:  Oncotarget       Date:  2014-11-30

9.  Loss of CDX2 gene expression is associated with DNA repair proteins and is a crucial member of the Wnt signaling pathway in liver metastasis of colorectal cancer.

Authors:  Csaba Tóth; Farkas Sükösd; Erzsébet Valicsek; Esther Herpel; Peter Schirmacher; László Tiszlavicz
Journal:  Oncol Lett       Date:  2018-01-09       Impact factor: 2.967

10.  Expression of ERCC1, RRM1, TUBB3 in correlation with apoptosis repressor ARC, DNA mismatch repair proteins and p53 in liver metastasis of colorectal cancer.

Authors:  Csaba Tóth; Farkas Sükösd; Erzsébet Valicsek; Esther Herpel; Peter Schirmacher; Marcus Renner; Christoph Mader; László Tiszlavicz; Jörg Kriegsmann
Journal:  Int J Mol Med       Date:  2017-09-14       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.